Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 37.86B | 37.87B | 31.54B | 20.10B | 12.60B | 8.77B |
Gross Profit | 7.35B | 8.55B | 4.53B | 4.65B | 3.58B | 2.72B |
EBITDA | 3.46B | 3.23B | 2.58B | 2.35B | 1.09B | 542.14M |
Net Income | 1.70B | 1.70B | 1.07B | 1.19B | 555.38M | 630.09M |
Balance Sheet | ||||||
Total Assets | 42.05B | 42.05B | 36.89B | 25.41B | 11.54B | 9.07B |
Cash, Cash Equivalents and Short-Term Investments | 3.47B | 3.47B | 1.21B | 1.25B | 697.10M | 1.07B |
Total Debt | 6.65B | 6.65B | 6.30B | 3.75B | 2.18B | 1.03B |
Total Liabilities | 23.80B | 23.80B | 20.12B | 9.98B | 5.71B | 3.64B |
Stockholders Equity | 17.50B | 17.50B | 16.13B | 15.40B | 5.72B | 5.36B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -600.76M | -4.51B | -1.89B | -1.03B | 177.32M |
Operating Cash Flow | 0.00 | 1.76B | -1.14B | -702.76M | -126.32M | 371.14M |
Investing Cash Flow | 0.00 | -1.05B | -281.80M | -9.14B | -3.99B | -1.12B |
Financing Cash Flow | 0.00 | -706.98M | 1.87B | 9.97B | 3.82B | 715.62M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ₹129.88B | 100.06 | 0.11% | 59.90% | 49.33% | ||
73 Outperform | ₹82.25B | 17.23 | 2.90% | 1.18% | -12.67% | ||
71 Outperform | ₹78.19B | 19.68 | 0.73% | 13.04% | 30.69% | ||
68 Neutral | ₹87.82B | 47.13 | ― | 34.69% | 12.48% | ||
67 Neutral | ₹140.09B | 64.73 | 0.21% | -3.83% | 103.23% | ||
66 Neutral | ₹88.59B | 45.73 | 1.06% | 26.47% | -21.31% | ||
61 Neutral | $36.05B | 6.66 | -10.10% | 1.86% | 8.68% | -8.81% |
Syrma SGS Technology Limited announced the passing of Mr. Satyendra Johari, the Chairman and Managing Director of its subsidiary, Syrma Johari Medtech Limited (formerly Johari Digital Healthcare Limited), on August 8, 2025. Mr. Johari, who was 77 years old and the founder of the subsidiary, leaves behind a legacy in the medtech industry. The board of Syrma Johari Medtech Limited will take necessary steps to ensure the continuity of operations, highlighting the company’s commitment to maintaining its business stability and honoring Mr. Johari’s contributions.
Syrma SGS Technology Limited has announced the opening of a Qualified Institutions Placement (QIP) of equity shares, with each share having a face value of ₹10, amounting to a total of ₹1,000 crore. The board of directors and shareholders have approved the issue, which is set at a floor price of ₹735.61 per share, with a potential discount of up to 5%. This move is part of the company’s strategic financial initiatives, and the trading window for designated persons will be closed until 48 hours after the issue price is determined.
Syrma SGS Technology Limited has announced the opening of a Qualified Institutions Placement (QIP) of equity shares, with a floor price set at ₹735.61 per share. This strategic move, approved by the board and shareholders, aims to enhance the company’s capital base and strengthen its market position. The trading window for designated persons is closed to comply with insider trading regulations, ensuring transparency and adherence to SEBI guidelines.